HONG KONG--(Marketwire - Jun 14, 2012) - Today, [ www.EquityLeader.com ] introduced research coverage of Abbott Laboratories (NYSE: [ ABT ]) and GlaxoSmithKline plc (ADR) (NYSE: [ GSK ]). Full research reports are available to readers at: [ www.EquityLeader.com/index.php?sm1=ABT&sm2=GSK ].

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Abbott Laboratories for its current position within the healthcare industry. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. A copy of this report detailing Abbott Laboratories (NYSE: [ ABT ]) is available at: [ www.EquityLeader.com/index.php?sm1=ABT ].

Equity Leader is also taking note of GlaxoSmithKline plc (ADR) for its changing role within the healthcare industry. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. To download free research on GlaxoSmithKline plc (ADR) (NYSE: [ GSK ]) investors may visit: [ www.EquityLeader.com/index.php?sm2=GSK ].

About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.